29
Implementing Guidelines For Thyroid Nodules Hirotoshi Nakamura Kuma Hospital, Kobe, Japan

Implementing Guidelines For Thyroid Nodules Hirotoshi Nakamura Kuma Hospital, Kobe, Japan

Embed Size (px)

Citation preview

Page 1: Implementing Guidelines For Thyroid Nodules Hirotoshi Nakamura Kuma Hospital, Kobe, Japan

Implementing Guidelines For Thyroid Nodules

Hirotoshi NakamuraKuma Hospital, Kobe,

Japan

Page 2: Implementing Guidelines For Thyroid Nodules Hirotoshi Nakamura Kuma Hospital, Kobe, Japan

1 . Purpose of this guidelines

2 . Classification and incidence of the nodules   2 - 1  Histological classification   2 - 2  Incidence of the nodules

3 .Algorithm for approaching thyroid nodules

4 .   Diagnostic approach4 - 1  Clinical evaluation4 - 2  Ultrasonography (US)

B-mode two-dimensional image  Doppler mode  US Elastography4 - 3  Fine Needle Aspiration4 - 4 CT 、 MR 、 PET 、 Scintigraphy  4 - 5  Laboratory tests & Molecular markers

Guidelines of Japan Thyroid Association for the management of thyroid nodules

5 .   Management and long-term follow-up5 - 1  Management based on FNA diagnosis5 - 2  TSH suppressive therapy5 - 3  Conditions for surgical treatment5 - 4  Treatment for papillary carcinoma  

6 .   Topics6 - 1  Adenomatous goiter   6 - 2  Cystic lesions6 - 3  Functioning nodules6 - 4  Nodules accompanied with Graves’

disease or Hashimoto thyroiditis6 - 5  Thyroid nodules during pregnancy6 - 6  Thyroid nodules in childhood

7 .   Clinical data about thyroid nodules in major medical institutes in Japan

8 .   Major guidelines outside Japan

(publish in 2013)

(Task Force : 29 doctors in endocrinology, endocrine surgery, radiology, nuclear medicine, pathology)

Page 3: Implementing Guidelines For Thyroid Nodules Hirotoshi Nakamura Kuma Hospital, Kobe, Japan

method region gender

nodules cancer rate of cancer

n rate n rate n of nodulescancer/  nodules

palpation

Japanmale 88858 0.64% 128664 0.08% 569 14.4%

female 289973 1.64% 469070 0.18% 4752 11.3%

outside Japanmale 9080 0.76%      

female 9990 3.10%        

ultrasonography

Japanmale 16811 16.6% 37459 0.26% 2795 1.9%

female 21907 28.1% 38524 0.66% 6164 3.2%

outside Japanmale 45500 20.1%      

female 40658 26.7%        

**

* **Maruchi et al. 1971Noguchi et al. 1985Yamashita et al. 1993Ishikawa et al. 1995Miki et al. 1998Suehiro et al. 2006

Ohara et al. 1986Saitoet al. 1991Yanohara et al. 1991Nakamutsu et al. 1993Sou et al. 1994Takebe et al. 1994

Karamatsu et al. 1996Shimuraet al. 2001Nishi et al. 2008Miyazaki et al. 2011

(summarized by Shimura)

Incidence of thyroid nodules discovered by palpation or ultrasonography in Japan

one of six males & one of 3.5 females

Page 4: Implementing Guidelines For Thyroid Nodules Hirotoshi Nakamura Kuma Hospital, Kobe, Japan

images

evaluation for thyroid nodules

cystic legion solid legion

123I- or99mTc-  scintigraphy

palpationthyroid nodules

history, physical exam ultrasonography TSH, (FT4) ( TgAb, TPOAb, Tg, Ct )

Fine Needle Aspiration Biopsy observation

Nondiagnostic Normal/Benign Indeterminate Suspicious for malignancy

Malignant

Suspicious for nodular lesion other than follicular tumor

AB

repeated FNA observation / US monitoring

surgical resection

Suspicious for follicular tumor

Page 5: Implementing Guidelines For Thyroid Nodules Hirotoshi Nakamura Kuma Hospital, Kobe, Japan

image

evaluation for thyroid nodules

cystic legion

solid legion

123I- or Tc-  scintigraphy

palpa-tion thyroid

nodules

history,physical exam

ultrasono-graphy

TSH, (FT4)   ( TgAb, TPOAb, Tg, Ct )

rapid growth of a masschildhood head and neck or total body irradiationfamily history of thyroid cancer (MTC, PTC) or thyroid cancer syndromes (MEN 2, Cowden synd, Carney complex, familial polyposis )

size, location, movement, consistency of the thyroid nodulescervical lymphadenopathyassociated local symptoms (pain, hoarseness, dysphagia, dysphonia, dyspnea)signs of hyper- or hypo-thyroidism

Page 6: Implementing Guidelines For Thyroid Nodules Hirotoshi Nakamura Kuma Hospital, Kobe, Japan

image

evaluation for thyroid nodules

cystic legion

solid legion

123I- or Tc-  scintigraphy

palpa-tion thyroid

nodules

history,physical exam

ultrasono-graphy

TSH, (FT4)   ( TgAb, TPOAb, Tg, Ct )

Measurement of serum TSH is necessary in every patient, since TSH is an independent risk factor for predicting malignancy.

If TSH is low and suppressed, a nodule may be hyperfunctioning.A hyperfunctioning nodule is usually benign.

The risk of malignancy rises in parallel with TSH, even within the normal range.Higher TSH was found to be associated with advanced-stage thyroid cancer.

Page 7: Implementing Guidelines For Thyroid Nodules Hirotoshi Nakamura Kuma Hospital, Kobe, Japan

cystic legion

solid legion

image

evaluation for thyroid nodules

123I- or Tc-  scintigraphy

palpa-tion thyroid

nodules

history,physical exam

ultrasono-graphy

TSH, (FT4)   ( TgAb, TPOAb, Tg, Ct )

TgAb and TPOAb are useful to identify the existence of Hashimoto thyroiditis which is known to co-associate with thyroid nodules at high frequency.

Page 8: Implementing Guidelines For Thyroid Nodules Hirotoshi Nakamura Kuma Hospital, Kobe, Japan

image

evaluation for thyroid nodules

cystic legion

solid legion

123I- or Tc-  scintigraphy

palpa-tion thyroid

nodules

history,physical exam

ultrasono-graphy

TSH, (FT4)   ( TgAb, TPOAb, Tg, Ct )

Serum Tg is not sensitive nor specific for the detection of thyroid cancer and not recommended to be measured in the initial evaluation. However, Tg measurement may be helpful in some occasions, since very high level of serum Tg has been reported in some cases of FTC.

Page 9: Implementing Guidelines For Thyroid Nodules Hirotoshi Nakamura Kuma Hospital, Kobe, Japan

image

evaluation for thyroid nodules

cystic legion

solid legion

123I- or Tc-  scintigraphy

palpa-tion thyroid

nodules

history,physical exam

ultrasono-graphy

TSH, (FT4)   ( TgAb, TPOAb, Tg, Ct )

We do not recommend serum calcitonin measurement in the initial evaluation, except for suspicious familial MTC or MEN type2. The prevalence of MTC in Japan is low and pentagastrin stimulation test is not available.

Page 10: Implementing Guidelines For Thyroid Nodules Hirotoshi Nakamura Kuma Hospital, Kobe, Japan

image

evaluation for thyroid nodules

cystic legion

solid legion

123I- or Tc-  scintigraphy

palpa-tion thyroid

nodules

history,physical exam

ultrasono-graphy

TSH, (FT4)   ( TgAb, TPOAb, Tg, Ct )

Thyroid ultrasonography should be performed in every patient with suspected thyroid nodule(s).It provides considerable anatomic detail and its findings can be used to select nodules for FNA biopsy.

Page 11: Implementing Guidelines For Thyroid Nodules Hirotoshi Nakamura Kuma Hospital, Kobe, Japan

image

evaluation for thyroid nodules

cystic legion

solid legion

123I- or Tc-  scintigraphy

palpa-tion thyroid

nodules

history,physical exam

ultrasono-graphy

TSH, (FT4)   ( TgAb, TPOAb, Tg, Ct )

Fine Needle Aspiration Biopsy

observation

Page 12: Implementing Guidelines For Thyroid Nodules Hirotoshi Nakamura Kuma Hospital, Kobe, Japan

US diagnostic findings  suspicious findings of malignancy

shape irregular, taller than wide

sharpness of border poorly defined, irregular

intensity of echoes hypoechoic

internal structure inhomogenous

calcification microcalcifications

Halo incomplete or absent

Doppler flow patterns central vascularity

Although none of these features alone is sufficient to differentiate a malignant nodule from majority of benign nodules, a combination of these can succeed in pointing out a lesion of high risk for malignancy.

Page 13: Implementing Guidelines For Thyroid Nodules Hirotoshi Nakamura Kuma Hospital, Kobe, Japan

US criteria for FNA biopsy of solid nodules

solid nodule

≦5mm> 5mm≦10mm

strongly suspicious

> 10mm≦20mm

suspicious finding(s)

FNAB

> 20mm

FNAB

FNAB++ --

observation

observation observation

Japan Association of Breast and Thyroid Sonology

FNAB is recommended for solid, hypoechoic nodule in diameter larger than 10mm.

Page 14: Implementing Guidelines For Thyroid Nodules Hirotoshi Nakamura Kuma Hospital, Kobe, Japan

cystic nodules

no solid legion

20mm≧

observation

presence of solid legion

size >10 mm

irregular, vascular, microcalcification

(+)(-)

20mm<

FNAC observationFNAB FNAB

US criteria for FNA biopsy of cystic nodules

Japan Association of Breast and Thyroid Sonology

or

Page 15: Implementing Guidelines For Thyroid Nodules Hirotoshi Nakamura Kuma Hospital, Kobe, Japan

Fine Needle Aspiration Cytology

Nondiagnostic

Normal ・ Benign

Indeterminate

Suspicious for

malignancy

Malignant

1

2

3

4

5

Diagnostic sample should contain   a minimum of 6 groupings of well-preserved thyroid epithelial cells, consisting of at least 10 cells per group.

FTC is difficult to be diagnosed by FNAC, since its diagnostic criteria include capsular invasion, vascular invasion and/or metastasis.

follicular adenoma/follicular carcinoma     follicular tumor any other lesions with atypia of undetermined significance

Diagnostic

( The Papanicolaou society of cytopathology.   1996)

Page 16: Implementing Guidelines For Thyroid Nodules Hirotoshi Nakamura Kuma Hospital, Kobe, Japan

The Bethesda System for Reporting Thyroid Cytopathology

IV.Follicular neoplasm

V.Suspicious for malignancy

5-10 %

20-30 %

(risk of malignancy)

II.Benign

I.Nondiagnostic

VI.Malignant

50-75 % 100 %

(Baloch et al.DiagnCytopathol, 2008)(Ali &Cibas(eds) 2009 The Bethesda System for Reporting Thyroid Cytopathology. Springer, NY)

< 3 %

III.Follicular lesion/Atypiaof undetermined significance

Page 17: Implementing Guidelines For Thyroid Nodules Hirotoshi Nakamura Kuma Hospital, Kobe, Japan

Fine Needle Aspiration Cytology

Indeterminate A

Indeterminate B

Suspicious of follicular tumor

Suspicious of nodular lesion other than follicular tumor

favor benign

(borderline)

favor malignant

3A

3B

(our new modified classification)

Nondiagnostic

Normal ・ Benign

Indeterminate

Suspicious for

malignancy

Malignant

1

2

3

4

5

Diagnostic

Page 18: Implementing Guidelines For Thyroid Nodules Hirotoshi Nakamura Kuma Hospital, Kobe, Japan

How to manage thyroid nodules based on the results of FNA

cytology ?

Page 19: Implementing Guidelines For Thyroid Nodules Hirotoshi Nakamura Kuma Hospital, Kobe, Japan

① Nondiagnostic specimen by FNAC

causes for nondiagnosticspecimen cystic nodules that yield few or no follicular cells, benign or malignant sclerotic lesions, nodules with a thick or calcified capsule,hypervascularor necrotic lesions, sampling errors or faulty biopsy techniques

How to manage thyroid nodules based on the results of FNA cytology ?

Diagnostic specimen should contain a minimum of 6 groupings of well-preserved thyroid epithelial cells, consisting of at least 10 cells per group.

Page 20: Implementing Guidelines For Thyroid Nodules Hirotoshi Nakamura Kuma Hospital, Kobe, Japan

① ‘Nondiagnostic’ specimen by FNAC

malignant rate: about 10%  

How to manage thyroid nodules based on the results of FNA cytology ?

repeat FNA with US guidanceRe-FNA with US guidance can yield a diagnostic specimen in 50-80%.

75% of solid nodules & 50% of cystic nodules (Alexander et al. JCEM 2002)

repeated nondiagnostic

consulting US findings

solid nodule(s) cystic lesion

surgical resection for histological diagnosis

close observation with US surveillance

Page 21: Implementing Guidelines For Thyroid Nodules Hirotoshi Nakamura Kuma Hospital, Kobe, Japan

② ‘benign’nodules by FNAC (1)

reported false negative rate : 1 ~ 11%

How to manage thyroid nodules based on the results of FNA cytology ?

mostly adenomatous nodule/ adenomatous goiternodular goiter or colloid nodule

(about ~3%?)

clinically follow up with repeated US assessment at 1~2 year intervals for several years

If the nodule show significant growth (>50% in

volume) or suspicious US changes, to repeat FNAB is recommended.

Page 22: Implementing Guidelines For Thyroid Nodules Hirotoshi Nakamura Kuma Hospital, Kobe, Japan

Repeated FNA increased the benign probability from 90% to 98%. (Oertel et al. Thyroid 2007)

Repeated FNA detected cancer in 13.2% initially diagnosed as benign nodules. (Gabales et al. Eur J Endocrinol 2009)

Repeated FNA detected cancer in 15/16 nodules initially diagnosed as benign. (Kwak et al. Eur Radiol 2009)

It would be advisable to repeate FNA up to three times.(Orlandi et al. Thyroid 2005)

Repeated FNA can increase the “benign” probability.

② ‘benign’nodules by FNAC (2)

How to manage thyroid nodules based on the results of FNA cytology ?

It may be recommended to repeat FNA after a couple of years for

affirmation of “benignancy”.

Page 23: Implementing Guidelines For Thyroid Nodules Hirotoshi Nakamura Kuma Hospital, Kobe, Japan

Should levothyroxine suppressive therapy be performed?

② ‘benign’nodules by FNAC (3)

How to manage thyroid nodules based on the results of FNA cytology ?

Since Japanese consume sufficient amount of iodine, routine T4 treatment to suppress TSH is not recommended.

Routine suppression therapy of benign thyroid nodules in iodine sufficient populations is not recommended. (ATA-GLRecommendation F)

Routine T4 treatment in patients with nodular thyroid disease is not recommended. T4 therapy may be considered in young patients who live in iodine-deficient areas. (AACE-GLGrade BLevel 3)

Page 24: Implementing Guidelines For Thyroid Nodules Hirotoshi Nakamura Kuma Hospital, Kobe, Japan

favor benign

borderline favor malig.

A-1 A-2 A-3

probability of

malignancy  5〜 15%

careful follow-up withUS

monitoring every 6~18 months

surgical resection for histological diagnosis

③ ‘Indeterminate A’by FNAC

How to manage thyroid nodules based on the results of FNA cytology ?

(Suspicious of follicular tumor)

probability of

malignancy  15〜 30%

probability of

malignancy  40〜 60%

follicular adenoma ?follicular carcinoma ?

Page 25: Implementing Guidelines For Thyroid Nodules Hirotoshi Nakamura Kuma Hospital, Kobe, Japan

④ ‘Indeterminate B’by FNAC (1)

How to manage thyroid nodules based on the results of FNA cytology ?

(Suspicious of nodular lesion other than follicular tumor)

• nodules with focal features suggestive of PTC in an otherwise benign-appearing sample

• Hashimoto thyroiditis / malignant lymphoma?

Repeated FNA at an appropriate interval is

recommended

A repeat FNA can result in a definitive diagnosis.Only about 20 – 25% of nodules are repeated AUS (Atypia of Undetermined Significance) in Bathesda System

(Yassa et al.Cancer2007)

Page 26: Implementing Guidelines For Thyroid Nodules Hirotoshi Nakamura Kuma Hospital, Kobe, Japan

⑤Suspicious for malignancy by FNAC

How to manage thyroid nodules based on the results of FNA cytology ?

probability of malignancy (PTC)   > 80%

⑥ Malignancy by FNAC probability of malignancy (PTC)   > 99%

very high probability of PTC

Surgical resectiontotal / near total thyroidectomylobectomy

Page 27: Implementing Guidelines For Thyroid Nodules Hirotoshi Nakamura Kuma Hospital, Kobe, Japan

images

evaluation for thyroid nodules

cystic legion solid legion

123I- or99mTc-  scintigraphy

palpationthyroid nodules

history, physical exam ultrasono-graphy TSH, (FT4) ( TgAb, TPOAb, Tg, Ct )

Fine Needle Aspiration Biopsy observation

Nondiagnostic Normal/Benign Indeterminate Suspicious for malignancy

Malignant

Suspicious for nodular lesion other than follicular tumor

AB

repeated FNA observation / US monitoring

surgical resection

Suspicious for follicular tumor

Page 28: Implementing Guidelines For Thyroid Nodules Hirotoshi Nakamura Kuma Hospital, Kobe, Japan

Thank you for your attention!

Page 29: Implementing Guidelines For Thyroid Nodules Hirotoshi Nakamura Kuma Hospital, Kobe, Japan